Cargando…

Urinary Cell Transcriptome Profiling and Identification of ITM2A, SLAMF6, and IKZF3 as Biomarkers of Acute Rejection in Human Kidney Allografts

Identification of a shared gene expression pattern between T cell–mediated rejection (TCMR) and antibody-mediated rejection (AMR) in human kidney allografts may help prioritize targets for the treatment of both types of acute rejection. METHODS. We performed RNA sequencing and bioinformatics of geno...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dooley, Bryan J., Verma, Akanksha, Ding, Ruchuang, Yang, Hua, Muthukumar, Thangamani, Lubetzky, Michele, Shankaranarayanan, Divya, Elemento, Olivier, Suthanthiran, Manikkam
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2020
Materias:	Kidney Transplantation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7377920/ https://www.ncbi.nlm.nih.gov/pubmed/32766436 http://dx.doi.org/10.1097/TXD.0000000000001035

Ejemplares similares

The Role of Complement Split-products as Biomarkers for Acute Antibody-mediated Rejection of Kidney Allografts
por: Abu Jawdeh, Bassam G., et al.
Publicado: (2022)

319 Optimizing Urinary cell mRNA profiling of kidney allograft recipients: Development of a home processing protocol for noninvasive diagnosis of T cell mediated rejection and BK virus nephropathy
por: Salinas, Thalia, et al.
Publicado: (2023)

Immunomics of Renal Allograft Acute T Cell-Mediated Rejection Biopsies of Tacrolimus- and Belatacept-Treated Patients
por: van der Zwan, Marieke, et al.
Publicado: (2018)

Acute Kidney Allograft Rejection Following Coronavirus mRNA Vaccination: A Case Report
por: Bau, Jason T., et al.
Publicado: (2022)

Rituximab in Combination With Bortezomib, Plasmapheresis, and High-Dose IVIG to Treat Antibody-Mediated Renal Allograft Rejection
por: Waiser, Johannes, et al.
Publicado: (2016)

Impact of Subclinical and Clinical Kidney Allograft Rejection Within 1 Year Posttransplantation Among Compatible Transplant With Steroid Withdrawal Protocol
por: Owoyemi, Itunu, et al.
Publicado: (2021)

Increased Autoantibodies Against Ro/SS-A, CENP-B, and La/SS-B in Patients With Kidney Allograft Antibody-mediated Rejection
por: Clotet-Freixas, Sergi, et al.
Publicado: (2021)

Utility of Serial Donor-derived Cell-free DNA Measurements for Detecting Allograft Rejection in a Kidney Transplant Recipient After PD-1 Checkpoint Inhibitor Administration
por: Lakhani, Laila, et al.
Publicado: (2021)

Influence of Cold Ischemia Time in Kidney Transplants From Small Pediatric Donors
por: Kayler, Liise K., et al.
Publicado: (2017)

Kidney Rejection Following Simultaneous Liver-kidney Transplantation
por: Shah, Sapna, et al.
Publicado: (2020)

Impact of Cold Ischemia Time in Kidney Transplants From Donation After Circulatory Death Donors
por: Kayler, Liise, et al.
Publicado: (2017)

Hyperacute Antibody-mediated Rejection Associated With Red Blood Cell Antibodies
por: Shaw, James, et al.
Publicado: (2019)

Alloreactive T cells to Assess Acute Rejection Risk in Kidney Transplant Recipients
por: Mendoza Rojas, Aleixandra, et al.
Publicado: (2023)

Magnetic Resonance Imaging for Evaluation of Interstitial Fibrosis in Kidney Allografts
por: Beck-Tölly, Andrea, et al.
Publicado: (2020)

Rituximab and Monitoring Strategies for Late Antibody-Mediated Rejection After Kidney Transplantation
por: Parajuli, Sandesh, et al.
Publicado: (2017)

Acute Rejection Phenotypes in the Current Era of Immunosuppression: A Single-Center Analysis
por: Wehmeier, Caroline, et al.
Publicado: (2017)

Effect of Maintaining Immunosuppression After Kidney Allograft Failure on Mortality and Retransplantation
por: Balakrishnan, Suryanarayanan, et al.
Publicado: (2022)

Complement Markers in Blood and Urine: No Diagnostic Value in Late Silent Antibody-Mediated Rejection
por: Mező, Blanka, et al.
Publicado: (2019)

Acute Rejection After Kidney Transplantation Associates With Circulating MicroRNAs and Vascular Injury
por: Bijkerk, Roel, et al.
Publicado: (2017)

Mast Cells in Kidney Transplant Biopsies With Borderline T Cell-mediated Rejection and Their Relation to Chronicity
por: Varol, Hilal, et al.
Publicado: (2023)

Identification of Antibiotic Administration as a Potentially Novel Factor Associated With Tacrolimus Trough Variability in Kidney Transplant Recipients: A Preliminary Study
por: Zheng, YuanPu, et al.
Publicado: (2019)

Early Kidney Allograft Dysfunction (Threatened Allograft): Comparative Effectiveness of Continuing Versus Discontinuation of Tacrolimus and Use of Sirolimus to Prevent Graft Failure: A Retrospective Patient-Centered Outcome Study
por: Wali, Ravinder K., et al.
Publicado: (2016)

Long-term Immunosuppression Adherence After Kidney Transplant and Relationship to Allograft Histology
por: Lorenz, Elizabeth C., et al.
Publicado: (2018)

Detecting Renal Allograft Inflammation Using Quantitative Urine Metabolomics and CXCL10
por: Ho, Julie, et al.
Publicado: (2016)

Efficacy and Safety of Tocilizumab in the Treatment of Acute Active Antibody-mediated Rejection in Kidney Transplant Recipients
por: Pottebaum, April A., et al.
Publicado: (2020)

A Combined microRNA and Chemokine Profile in Urine to Identify Rejection After Kidney Transplantation
por: Gielis, Els M., et al.
Publicado: (2021)

Causes of Renal Allograft Injury in Recipients With Normal Donor-derived Cell-free DNA
por: Xie, Wen Yan, et al.
Publicado: (2021)

Absence of Intragraft B Cells in Rejection Biopsies After Rituximab Induction Therapy: Consequences for Clinical Outcome
por: van den Hoogen, Martijn W.F., et al.
Publicado: (2017)

Response to Treatment for Chronic-active T Cell–mediated Rejection in Kidney Transplantation: A Report of 3 Cases
por: Noguchi, Hiroshi, et al.
Publicado: (2020)

Rejection-associated Phenotype of De Novo Thrombotic Microangiopathy Represents a Risk for Premature Graft Loss
por: Petr, Vojtech, et al.
Publicado: (2021)

How Should Acute T-cell Mediated Rejection of Kidney Transplants Be Treated: Importance of Follow-up Biopsy
por: Aziz, Fahad, et al.
Publicado: (2022)

Procurement Biopsy Findings Versus Kidney Donor Risk Index for Predicting Renal Allograft Survival
por: Hall, Isaac E., et al.
Publicado: (2018)

High Calcineurin Inhibitor Intrapatient Variability Is Associated With Renal Allograft Inflammation, Chronicity, and Graft Loss
por: Sharma, Akhil, et al.
Publicado: (2019)

Open-Label, Randomized Study of Transition From Tacrolimus to Sirolimus Immunosuppression in Renal Allograft Recipients
por: Tedesco-Silva, Helio, et al.
Publicado: (2016)

Challenges in the Management of Kidney Allograft Herniation With a Single-stage Pedicled Anterolateral Thigh Flap
por: Bevilacqua, Ruggero, et al.
Publicado: (2022)

The Association Between Broad Antigen HLA Mismatches, Eplet HLA Mismatches and Acute Rejection After Kidney Transplantation
por: Do Nguyen, Hung Thanh, et al.
Publicado: (2016)

Class and Kinetics of Weakly Reactive Pretransplant Donor-specific HLA Antibodies Predict Rejection in Kidney Transplant Recipients
por: Morrison, Alexander H., et al.
Publicado: (2019)

Treatment of Chronic Active Antibody-mediated Rejection With Pulse Steroids, IVIG, With or Without Rituximab is Associated With Increased Risk of Pneumonia
por: Joachim, Emily, et al.
Publicado: (2020)

Chronic Active Antibody-mediated Rejection in Kidney Transplant Recipients: Treatment Response Rates and Value of Early Surveillance Biopsies
por: Aziz, Fahad, et al.
Publicado: (2022)

Antithrombin Perfluorocarbon Nanoparticles Improve Renal Allograft Function in a Murine Deceased Criteria Donor Model
por: Vemuri, Chandu, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_e56g084asstgkud5hc7tujkbu5